Full-papers

Year Pmid Doi Title Journal Authors
20264199585210.1007/s00277-026-06900-wHealth-related quality of life of patients with acute myeloid leukemia and myelodysplastic syndromes/neoplasms treated with decitabine: a systematic literature review.Annals of hematologyCannella L, Venditti A, Palmieri R, Puglia S, Luppi M, Breccia M, Efficace F
20264197497010.1007/s00520-026-10682-2The importance of better understanding symptom trajectories in the evolving treatment landscape of acute myeloid leukemia.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerNiscola P, Giovannini M, Efficace F
20264187621010.1136/spcare-2025-006013Quality of life and symptoms in acute myeloid leukaemia with early palliative care: real-world observational study.BMJ supportive & palliative carePotenza L, Giusti D, Borelli E, Colaci E, Morandi F, Cuoghi Costantini R, Del Giovane C, Forghieri F, Morselli M, Bettelli F, Pioli V, Cuoghi A, Bresciani P, Messerotti A, Gilioli A, Marasca R, Cassanelli L, Parisotto A, Cretì F, Mucciarini C, Bigi S, D'Amico R, Efficace F, Odejide O, Bruera E, Zimmermann C, Luppi M, Bandieri E
20264180417110.1093/oncolo/oyag027Long-term health-related quality of life and lifestyle behavior of patients with acute myeloid leukemia.The oncologistEfficace F, Cannella L, Thomas X, Yuksel MK, Trisolini SM, Capria S, Sparano F, Baldi T, Audisio E, Maurillo L, Lemoli RM, Imovilli A, Panovska-Stavridis I, Quattrone M, Ciccone M, Filardi N, Fracchiolla N, Vallisa D, Crugnola M, Melillo LMA, Skerget M, Vignetti M, Baron F,
20254147300310.1002/hem3.70274Health-related quality of life and symptom profile of patients with -negative myeloproliferative neoplasms: Real-world evidence from the GIMEMA-PROPHECY observational study.HemaSphereCaocci G, Costa A, Palandri F, Guglielmelli P, Patriarca A, Iurlo A, Tieghi A, Abruzzese E, Baldi T, Rossi E, Beggiato E, Marchetti M, Fava C, Tomassetti S, Rumi E, Fozza C, Luppi M, Pane F, Bigliardi S, Breccia M, Elli EM, Tartaglia F, Mulas O, Fazi P, Vignetti M, Vannucchi AM, Efficace F
20254106830310.1007/s00277-025-06594-6Understanding challenges and barriers to quality end-of-life care for patients with hematologic malignancies: a GIMEMA survey.Annals of hematologyPotenza L, Efficace F, Borelli E, Fazi P, Baldi T, Tartaglia F, Sparano F, Cartoni C, Niscola P, Mucciarini C, Odejide O, Bruera E, Zimmermann C, Vignetti M, Luppi M, Bandieri E
20254105259810.1016/j.jcpo.2025.100645Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patients.Journal of cancer policyArenare L, Porta C, Barberio D, Terzolo S, Zagonel V, Pisconti S, Del Mastro L, Pinto C, Bilancia D, Cinieri S, Rizzo M, Migliaccio G, Montesarchio V, Del Campo L, De Lorenzo F, Iannellil E, Gitto L, Vaccaro CM, Frontini L, Giannarelli D, Bryce J, Iacovino ML, Piccirillo MC, Jommi C, Efficace F, Riva S, Di Maio M, Gallo C, Perrone F
20254093672310.3389/fonc.2025.1645217The prognostic value of health-related quality of life for early molecular response in patients with chronic myeloid leukemia: analysis of the GIMEMA-SUSTRENIM trial.Frontiers in oncologyEfficace F, Cannella L, Capodanno I, Sancetta R, Porcu V, Lunghi M, Biagi A, Castagnetti F, Caocci G, Baldi T, Marasca R, Bonifacio M, Gozzini A, Martino B, Sora F, Westerweel PE, Fazi P, Vignetti M, Pane F, Breccia M
20254084403710.1080/14737140.2025.2550804Advancing patient-centered care in myelodysplastic syndromes/neoplasms with oral therapies.Expert review of anticancer therapyNiscola P, Efficace F
20254080898410.1177/22799036251361377Clinician's knowledge and awareness of patient-reported outcomes in immune thrombocytopenia: Results of a national survey (ITP NET, GIMEMA Working Group Anemia and Thrombocytopenia).Journal of public health researchOliva EN, Efficace F, Valvano MR, Arcuri P, Battistini R, Buzzatti E, Clissa C, Danesin C, Salemme A, Sparano F, Ramundo F, Consoli U, Chiurazzi F
20254072946510.1111/ejh.70002Quality of Patient-Reported Outcomes in Multiple Myeloma Randomized Controlled Trial Protocols and Publications According to the SPIRIT-PRO and CONSORT-PRO guidelines: A Systematic Review.European journal of haematologyShah D, Sparano F, Shah V, Krepper D, Baldi T, Chakraborty R, Efficace F
20254069795810.1016/j.eclinm.2025.103354Exploring patient-reported outcomes and morbidity burden of patients with VEXAS syndrome: a scoping review.EClinicalMedicineEfficace F, Krepper D, Sparano F, Fazi P, Voso MT, Gurnari C
20254054692710.1136/bmjonc-2025-000783Patient-reported outcomes (PROs) in clinical trials and in clinical practice: report from the XXI national conference of the Italian Association of Medical Oncology (AIOM).BMJ oncologyPuccini A, Viscardi G, Ciani O, Efficace F, Piattelli A, Beretta GD, Petruzzelli D, Popoli P, De Lorenzo F, Longo F, Zibellini M, Gitto L, Brunello A, Maiello E, Servetto A, Pagliuca M, Raimondi A, Marandino L, Cinieri S, Iannelli E, Ripamonti CI, Bossi P, Numico G, Latiano T, Pinto C, Quaglini S, Locati L, Gussoni G, Mignone G, Carrera PM, Basch E, Di Maio M, Perrone F
20254047257310.1016/j.jgo.2025.102266Assessing frailty in patients with relapsed/refractory multiple myeloma: A comparison between the patient-reported frailty phenotype and the International Myeloma Working Group frailty index.Journal of geriatric oncologyKrepper D, Sparano F, Giesinger JM, Gaidano G, Niscola P, Codeluppi K, Antonioli E, Califano C, Floro L, Annibali O, Fozza C, Tafuri A, Mazza P, Potenza L, Vignetti M, Cavo M, Petrucci MT, Efficace F
20254019446810.1016/j.ejca.2025.115392Flexibility in patient-reported outcome and health-related quality of life measurement: The EORTC Quality of Life Group measurement strategy.European journal of cancer (Oxford, England : 1990)Piccinin C, Aaronson NK, Bjordal K, Coens C, Darlington AS, Efficace F, Fitzsimmons D, Giesinger JM, Gilbert A, Holzner B, Kuliś D, Nolte S, Pe M, Petersen MA, Reijneveld JC, Singer S, Sprangers MAG, Taphoorn MJB, Tomaszewski KA, van de Poll-Franse L, Velikova G, Wheelwright S, Groenvold M,
20254018737810.1016/j.jpainsymman.2025.03.029Early Palliative Care, Goals of Care Conversations and Quality EOL Care in Acute Leukemia and HR-MDS.Journal of pain and symptom managementPotenza L, Giusti D, Borelli E, Colaci E, Banchelli F, Cuoghi Costantini R, Forghieri F, Morselli M, Bettelli F, Pioli V, Cuoghi A, Bresciani P, Messerotti A, Gilioli A, Marasca R, Candoni A, Cassanelli L, Parisotto A, Martini E, Morandi F, Bigi S, D'Amico R, Efficace F, Odejide O, Bruera E, Zimmermann C, Luppi M, Bandieri E
20253983693410.1200/JCO-24-02021Timely Reporting of Patient-Reported Outcomes in Cancer Clinical Trials: An Ethical Imperative.Journal of clinical oncology : official journal of the American Society of Clinical OncologyBlackstone EC, Efficace F, Meyerhardt JA, Abel GA
20253966867110.1097/CMR.0000000000001014Patient-reported outcomes in randomized controlled trials evaluating BRAF inhibitors in patients with cutaneous melanoma: a systematic scoping review of quality of reporting and trial results.Melanoma researchAl-Naesan I, Krepper D, Sparano F, Sztankay M, Efficace F, Giesinger JM
20253872422210.1136/spcare-2024-004924Financial toxicity and health-related quality of life in long-term survivors of acute promyelocytic leukaemia.BMJ supportive & palliative careSparano F, Voso MT, Venditti A, Giesinger JM, Baldi T, Breccia M, Fazi P, Vignetti M, Efficace F
20243964433410.1007/s00277-024-06129-5Patient-reported outcome domains in multiple myeloma randomized controlled trials and association with survival outcomes.Annals of hematologyShah D, Sparano F, Luo C, Krepper D, Giesinger JM, Baldi T, Duncan E, Pe M, Chakraborty R, Efficace F
20243961923910.1016/j.eclinm.2024.102914Health-related quality of life outcomes in randomized controlled trials in metastatic hormone-sensitive prostate cancer: a systematic review.EClinicalMedicineOsanto S, Vliert-Bout AV, Gomez de Segura CA, Efficace F, Sparano F, Willemse PP, Schoones J, Cohen A, Barjesteh van Waalwijk van Doorn-Khosrovani S
20243954156010.1200/GO-24-00281Health-Related Quality of Life and Financial Burden in Ethiopian Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional Study.JCO global oncologyTadesse F, Sparano F, Gebremedhin A, Abubeker A, Piciocchi A, Cipriani M, Krepper D, Gemechu L, Mulu A, Asres G, Efficace F
20243943832210.1007/s00277-024-06038-7Health-related quality of life benefits of arsenic trioxide in patients with non-high-risk acute promyelocytic leukemia are sustained over time: long-term results of the GIMEMA APL0406 trial.Annals of hematologyEfficace F, Sparano F, Breccia M, Greco C, Carluccio P, Borlenghi E, Salutari P, Levato L, Baldi T, Mancini V, Finizio O, Autore F, Fazi P, Platzbecker U, Vignetti M, Voso MT
20243932211810.1016/j.modpat.2024.100615Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes-Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS]).Modern pathology : an official journal of the United States and Canadian Academy of Pathology, IncAakash F, Gisriel SD, Zeidan AM, Bennett JM, Bejar R, Bewersdorf JP, Borate UM, Boultwood J, Brunner AM, Buckstein R, Carraway HE, Churpek JE, Daver NG, DeZern AE, Efficace F, Fenaux P, Figueroa ME, Garcia-Manero G, Gore SD, Greenberg PL, Griffiths EA, Halene S, Hourigan CS, Kim TK, Kim N, Komrokji RS, Kutchroo VK, List AF, Little RF, Majeti R, Nazha A, Nimer SD, Odenike O, Padron E, Patnaik MM, Platzbecker U, Della Porta MG, Roboz GJ, Sallman DA, Santini V, Sanz G, Savona MR, Sekeres MA, Stahl M, Starczynowski DT, Steensma DP, Taylor J, Abdel-Wahab O, Wei AH, Xie Z, Xu ML, Hasserjian RP, Loghavi S
20243907843610.1007/s00277-024-05914-6Response to Dr. Ying Cui comments.Annals of hematologyMulas O, Efficace F, Costa A, Baldi T, Zerbini F, Mantovani D, Morelli E, Perra D, La Nasa G, Caocci G
20243900234610.1016/j.ejca.2024.114210Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort.European journal of cancer (Oxford, England : 1990)Anota A, Basset M, Charton E, Bommier C, Efficace F, Dupuis J, Cottone F, Bouabdallah KK, Mollevi C, Ysebaert L, Winter A, Bijou F, Préau M, Chauchet A, Bernier A, Fornecker LM, Hafirassou H, Carras S, Lachenal F, Lionne-Huyghe P, Detourmignies L, Leyronnas C, Drénou B, Peyrou SLG, Abraham J, Monnereau A, Fouillet L, Morschhauser F, Rossi C, Belot A, Ghesquières H
20243898727410.1038/s41375-024-02341-4Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial.LeukemiaEfficace F, Mahon FX, Richter J, Piciocchi A, Cipriani M, Nicolini FE, Mayer J, Zackova D, Janssen JJWM, Panayiotidis P, Vestergaard H, Koskenvesa P, Almeida A, Hjorth-Hansen H, Martinez-Lopez J, Olsson-Strömberg U, Hochhaus A, Berger MG, Etienne G, Klamova H, Faber E, Rousselot P, Pfirrmann M, Saussele S
20243877465510.1002/hem3.69Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS).HemaSphereEfficace F, Buckstein R, Abel GA, Giesinger JM, Fenaux P, Bewersdorf JP, Brunner AM, Bejar R, Borate U, DeZern AE, Greenberg P, Roboz GJ, Savona MR, Sparano F, Boultwood J, Komrokji R, Sallman DA, Xie Z, Sanz G, Carraway HE, Taylor J, Nimer SD, Della Porta MG, Santini V, Stahl M, Platzbecker U, Sekeres MA, Zeidan AM
20243874444710.1136/spcare-2024-004842Early palliative care perceptions by patients with cancer and primary caregivers: metaphorical language.BMJ supportive & palliative careBandieri E, Bigi S, Nava M, Borelli E, Porro CA, Castellucci E, Efficace F, Bruera E, Odejide O, Zimmermann C, Potenza L, Luppi M
20243871786110.1182/blood.2023023625Decitabine in older patients with AML: quality of life results of the EORTC-GIMEMA-GMDS-SG randomized phase 3 trial.BloodEfficace F, Kicinski M, Coens C, Suciu S, van der Velden WJFM, Noppeney R, Chantepie S, Griskevicius L, Neubauer A, Audisio E, Luppi M, Fuhrmann S, Foà R, Crysandt M, Gaidano G, Vrhovac R, Venditti A, Posthuma EFM, Candoni A, Baron F, Legrand O, Mengarelli A, Fazi P, Vignetti M, Giraut A, Wijermans PW, Huls G, Lübbert M
20243867129810.1007/s00277-024-05771-3Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura.Annals of hematologyMulas O, Efficace F, Costa A, Baldi T, Zerbini F, Mantovani D, Morelli E, Perra D, La Nasa G, Caocci G
20243860660510.7189/jogh-14-04068Key lifestyles and health outcomes across 16 prevalent chronic diseases: A network analysis of an international observational study.Journal of global healthLi J, Fong DYT, Lok KYW, Wong JYH, Man Ho M, Choi EPH, Pandian V, Davidson PM, Duan W, Tarrant M, Lee JJ, Lin CC, Akingbade O, Alabdulwahhab KM, Ahmad MS, Alboraie M, Alzahrani MA, Bilimale AS, Boonpatcharanon S, Byiringiro S, Hasan MKC, Schettini LC, Corzo W, De Leon JM, De Leon AS, Deek H, Efficace F, El Nayal MA, El-Raey F, Ensaldo-Carrasco E, Escotorin P, Fadodun OA, Fawole IO, Goh YS, Irawan D, Khan NE, Koirala B, Krishna A, Kwok C, Le TT, Leal DG, Lezana-Fernández MÁ, Manirambona E, Mantoani LC, Meneses-González F, Mohamed IE, Mukeshimana M, Nguyen CTM, Nguyen HTT, Nguyen KT, Nguyen ST, Nurumal MS, Nzabonimana A, Omer NAMA, Ogungbe O, Poon ACY, Reséndiz-Rodriguez A, Puang-Ngern B, Sagun CG, Shaik RA, Shankar NG, Sommer K, Toro E, Tran HTH, Urgel EL, Uwiringiyimana E, Vanichbuncha T, Youssef N
20243858222710.1016/j.critrevonc.2024.104345Patient-reported outcomes in randomized clinical trials of systemic therapy for advanced soft tissue sarcomas in adults: A systematic review.Critical reviews in oncology/hematologyRoets E, van der Graaf W, van Riet BHG, Haas RL, Younger E, Sparano F, Wilson R, van der Mierden S, Steeghs N, Efficace F, Husson O
20243847802310.1007/s00277-024-05704-0Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the "RAMP" Italian multicenter prospective study.Annals of hematologyPalandri F, Auteri G, Abruzzese E, Caocci G, Bonifacio M, Mendicino F, Latagliata R, Iurlo A, Branzanti F, Garibaldi B, Trawinska MM, Cattaneo D, Krampera M, Mulas O, Martino EA, Cavo M, Vianelli N, Impera S, Efficace F, Heidel F, Breccia M, Elli EM, Palumbo GA
20243842421410.1038/s41591-024-02827-9Recommendations to address respondent burden associated with patient-reported outcome assessment.Nature medicineAiyegbusi OL, Cruz Rivera S, Roydhouse J, Kamudoni P, Alder Y, Anderson N, Baldwin RM, Bhatnagar V, Black J, Bottomley A, Brundage M, Cella D, Collis P, Davies EH, Denniston AK, Efficace F, Gardner A, Gnanasakthy A, Golub RM, Hughes SE, Jeyes F, Kern S, King-Kallimanis BL, Martin A, McMullan C, Mercieca-Bebber R, Monteiro J, Peipert JD, Quijano-Campos JC, Quinten C, Rantell KR, Regnault A, Sasseville M, Schougaard LMV, Sherafat-Kazemzadeh R, Snyder C, Stover AM, Verdi R, Wilson R, Calvert MJ
20243820723910.1200/OP.23.00434Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System.JCO oncology practiceSparano F, Giesinger JM, Gaidano G, Anota A, Cavo M, Brini A, Voso MT, Venditti A, Perrone F, Di Maio M, Luppi M, Baron F, Platzbecker U, Fazi P, Vignetti M, Efficace F
20243817497710.1002/ajh.27196Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long-term follow-up of the EORTC-GIMEMA randomized AML-10 trial.American journal of hematologyBaron F, Efficace F, Cannella L, Stevens-Kroef M, Amadori S, de Witte T, Lübbert M, Venditti A, Suciu S
20243780105210.1002/cncr.35021Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia.CancerEfficace F, Cottone F, Yanez B, Kota V, Castagnetti F, Caocci G, Bonifacio M, Patriarca A, Capodanno I, Miggiano MC, Tiribelli M, Breccia M, Luciano L, Giai V, Iurlo A, Abruzzese E, Fava C, Dinner S, Altman JK, Rosti G, Cortes J, Vignetti M, Cella D
20243775199510.1136/spcare-2023-004524Early palliative care versus usual haematological care in multiple myeloma: retrospective cohort study.BMJ supportive & palliative careGiusti D, Colaci E, Pioli V, Banchelli F, Maccaferri M, Leonardi G, Marasca R, Morselli M, Forghieri F, Bettelli F, Cuoghi A, Bresciani P, Messerotti A, Gilioli A, Candoni A, Cassanelli L, Sbadili E, Bassoli I, Longo G, Gilioli F, Borelli E, Bigi S, D'Amico R, Porro CA, Odejide O, Zimmermann C, Efficace F, Bruera E, Luppi M, Bandieri E, Potenza L
20243561841210.1136/bmjspcare-2022-003572Edmonton symptom assessment system global distress score and overall survival among patients with advanced cancer receiving early palliative care.BMJ supportive & palliative careBandieri E, Banchelli F, Borelli E, D'Amico R, Efficace F, Bruera E, Luppi M, Potenza L
20233805210410.1016/j.esmoop.2023.102192Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients.ESMO openArenare L, Porta C, Barberio D, Terzolo S, Zagonel V, Pisconti S, Del Mastro L, Pinto C, Bilancia D, Cinieri S, Rizzo M, Migliaccio G, Montesarchio V, Del Campo L, De Lorenzo F, Iannelli E, Traclò F, Gitto L, Vaccaro MC, Frontini L, Giannarelli D, Bryce J, Piccirillo MC, Jommi C, Efficace F, Riva S, Di Maio M, Gallo C, Perrone F
20233791448210.1016/S2352-3026(23)00273-910-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial.The Lancet. HaematologyLübbert M, Wijermans PW, Kicinski M, Chantepie S, Van der Velden WJFM, Noppeney R, Griškevičius L, Neubauer A, Crysandt M, Vrhovac R, Luppi M, Fuhrmann S, Audisio E, Candoni A, Legrand O, Foà R, Gaidano G, van Lammeren-Venema D, Posthuma EFM, Hoogendoorn M, Giraut A, Stevens-Kroef M, Jansen JH, de Graaf AO, Efficace F, Ammatuna E, Vilque JP, Wäsch R, Becker H, Blijlevens N, Dührsen U, Baron F, Suciu S, Amadori S, Venditti A, Huls G,
20233786113010.7189/jogh.13.04125Key lifestyles and interim health outcomes for effective interventions in general populations: A network analysis of a large international observational study.Journal of global healthLi J, Fong DYT, Lok KYW, Wong JYH, Ho MM, Choi EPH, Pandian V, Davidson PM, Duan W, Tarrant M, Lee JJ, Lin CC, Akingbade O, Alabdulwahhab KM, Ahmad MS, Alboraie M, Alzahrani MA, Bilimale AS, Boonpatcharanon S, Byiringiro S, Hasan MKC, Schettini LC, Corzo W, De Leon JM, De Leon AS, Deek H, Efficace F, El Nayal MA, El-Raey F, Ensaldo-Carrasco E, Escotorin P, Fadodun OA, Fawole IO, Goh YS, Irawan D, Khan NE, Koirala B, Krishna A, Kwok C, Le TT, Leal DG, Lezana-Fernández MÁ, Manirambona E, Mantoani LC, Meneses-González F, Mohamed IE, Mukeshimana M, Nguyen CTM, Nguyen HTT, Nguyen KT, Nguyen ST, Nurumal MS, Nzabonimana A, Omer NAMA, Ogungbe O, Poon ACY, Reséndiz-Rodriguez A, Puang-Ngern B, Sagun CG, Shaik RA, Shankar NG, Sommer K, Toro E, Tran HTH, Urgel EL, Uwiringiyimana E, Vanichbuncha T, Youssef N
20233778119210.3389/fonc.2023.1213906Caregiver's quality of life in advanced cancer: validation of the construct in a real-life setting of early palliative care.Frontiers in oncologyBorelli E, Bigi S, Potenza L, Gilioli F, Efficace F, Porro CA, Luppi M, Bandieri E
20233776298710.3390/jcm12186047Health-Related Quality-of-Life Profile of Pediatric Patients with β Thalassemia after Hematopoietic Stem Cell Transplantation.Journal of clinical medicineMulas O, Efficace F, Orofino MG, Piroddi A, Piras E, Vacca A, Barella S, Costa A, Giesinger JM, La Nasa G, Caocci G
20233770446910.1016/j.blre.2023.101128Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).Blood reviewsStahl M, Bewersdorf JP, Xie Z, Porta MGD, Komrokji R, Xu ML, Abdel-Wahab O, Taylor J, Steensma DP, Starczynowski DT, Sekeres MA, Sanz G, Sallman DA, Roboz GJ, Platzbecker U, Patnaik MM, Padron E, Odenike O, Nimer SD, Nazha A, Majeti R, Loghavi S, Little RF, List AF, Kim TK, Hourigan CS, Hasserjian RP, Halene S, Griffiths EA, Gore SD, Greenberg P, Figueroa ME, Fenaux P, Efficace F, DeZern AE, Daver NG, Churpek JE, Carraway HE, Buckstein R, Brunner AM, Boultwood J, Borate U, Bejar R, Bennett JM, Wei AH, Santini V, Savona MR, Zeidan AM
20233766367110.1097/HS9.0000000000000944Health-related Quality of Life Profile of Newly Diagnosed Patients With Myelodysplastic Syndromes by Age, Sex, and Risk Group: A Real-world Study by the GIMEMA.HemaSphereEfficace F, Al Essa W, Platzbecker U, Niscola P, Palumbo GA, Caocci G, Cottone F, Breccia M, Luppi M, Stauder R, Ricco A, Petranovic D, Baron F, Voso MT, Fianchi L, Frairia C, Capodanno I, Sarlo C, Fedele M, Lemoli RM, Invernizzi R, Vallisa D, Di Renzo N, Fozza C, Doro M, Giesinger JM, Vignetti M
20233763470210.1016/j.jclinepi.2023.08.009The estimand framework had implications in time to patient-reported outcomes deterioration analyses in cancer clinical trials.Journal of clinical epidemiologyCottone F, Efficace F, Cella D, Aaronson NK, Giesinger JM, Bachet JB, Louvet C, Charton E, Collins GS, Anota A
20233756539410.7189/jogh.13.06031Global impacts of COVID-19 on lifestyles and health and preparation preferences: An international survey of 30 countries.Journal of global healthLi J, Fong DYT, Lok KYW, Wong JYH, Man Ho M, Choi EPH, Pandian V, Davidson PM, Duan W, Tarrant M, Lee JJ, Lin CC, Akingbade O, Alabdulwahhab KM, Ahmad MS, Alboraie M, Alzahrani MA, Bilimale AS, Boonpatcharanon S, Byiringiro S, Hasan MKC, Schettini LC, Corzo W, De Leon JM, De Leon AS, Deek H, Efficace F, El Nayal MA, El-Raey F, Ensaldo-Carrasco E, Escotorin P, Fadodun OA, Fawole IO, Goh YS, Irawan D, Khan NE, Koirala B, Krishna A, Kwok C, Le TT, Leal DG, Lezana-Fernández MÁ, Manirambona E, Mantoani LC, Meneses-González F, Mohamed IE, Mukeshimana M, Nguyen CTM, Nguyen HTT, Nguyen KT, Nguyen ST, Nurumal MS, Nzabonimana A, Omer NAMA, Ogungbe O, Poon ACY, Reséndiz-Rodriguez A, Puang-Ngern B, Sagun CG, Shaik RA, Shankar NG, Sommer K, Toro E, Tran HTH, Urgel EL, Uwiringiyimana E, Vanichbuncha T, Youssef N
20233751750410.1016/j.jclinepi.2023.07.012Information about missing patient-reported outcome data in breast cancer trials is frequently not documented: a scoping review.Journal of clinical epidemiologyKrepper D, Giesinger JM, Dirven L, Efficace F, Martini C, Thurner AMM, Al-Naesan I, Gross F, Sztankay MJ
20233750931710.3390/cancers15143656Stigma of Palliative Care among Patients with Advanced Cancer and Their Caregivers on Early Palliative Care.CancersBandieri E, Borelli E, Gilioli F, Bigi S, Mucciarini C, Ferrari U, Eliardo S, Pinto L, Porro CA, Efficace F, Luppi M, Potenza L
20233704863010.3390/jcm12072547Long-Term Health-Related Quality of Life and Clinical Outcomes in Patients with β-Thalassemia after Splenectomy.Journal of clinical medicineCaocci G, Mulas O, Barella S, Orecchia V, Mola B, Costa A, Efficace F, La Nasa G
20233686421010.1007/s00277-023-05149-xThe prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial.Annals of hematologyGudmundstuen AM, Efficace F, Tjønnfjord GE, Skaarud KJ, Cottone F, Hjermstad MJ, Iversen PO
20233672445310.1182/blood.2022018604Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes.BloodZeidan AM, Platzbecker U, Bewersdorf JP, Stahl M, Adès L, Borate U, Bowen D, Buckstein R, Brunner A, Carraway HE, Daver N, Díez-Campelo M, de Witte T, DeZern AE, Efficace F, Garcia-Manero G, Garcia JS, Germing U, Giagounidis A, Griffiths EA, Hasserjian RP, Hellström-Lindberg E, Iastrebner M, Komrokji R, Kulasekararaj AG, Malcovati L, Miyazaki Y, Odenike O, Santini V, Sanz G, Scheinberg P, Stauder R, van de Loosdrecht AA, Wei AH, Sekeres MA, Fenaux P
20233660783210.1182/bloodadvances.2022008360Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study.Blood advancesStojkov I, Conrads-Frank A, Rochau U, Arvandi M, Koinig KA, Schomaker M, Mittelman M, Fenaux P, Bowen D, Sanz GF, Malcovati L, Langemeijer S, Germing U, Madry K, Guerci-Bresler A, Culligan DJ, Kotsianidis I, Sanhes L, Mills J, Puntscher S, Schmid D, van Marrewijk C, Smith A, Efficace F, de Witte T, Stauder R, Siebert U
20233653341510.1002/cam4.5487Raising the standards of patient-centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS-RIGHT project.Cancer medicineEfficace F, Koinig K, Cottone F, Bowen D, Mittelman M, Sommer K, Langemeijer S, Culligan D, Filanovsky K, Storck M, Smith A, van Marrewijk C, Dugas M, Stojkov I, Siebert U, de Witte T, Stauder R
20233632012810.1093/oncolo/oyac227Perceptions of Death Among Patients with Advanced Cancer Receiving Early Palliative Care and Their Caregivers: Results from a Mixed-Method Analysis.The oncologistBigi S, Ganfi V, Borelli E, Potenza L, Artioli F, Eliardo S, Mucciarini C, Cottafavi L, Ferrari U, Lombardo L, Cagossi K, Pietramaggiori A, Fantuzzi V, Bernardini I, Cruciani M, Cacciari C, Odejide O, Adolfo Porro C, Zimmermann C, Efficace F, Bruera E, Luppi M, Bandieri E
20233626070210.1182/bloodadvances.2022008747An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS.Blood advancesStahl M, Abdel-Wahab O, Wei AH, Savona MR, Xu ML, Xie Z, Taylor J, Starczynowski D, Sanz GF, Sallman DA, Santini V, Roboz GJ, Patnaik MM, Padron E, Odenike O, Nazha A, Nimer SD, Majeti R, Little RF, Gore S, List AF, Kutchroo V, Komrokji RS, Kim TK, Kim N, Hourigan CS, Hasserjian RP, Halene S, Griffiths EA, Greenberg PL, Figueroa M, Fenaux P, Efficace F, DeZern AE, Della Porta MG, Daver NG, Churpek JE, Carraway HE, Brunner AM, Borate U, Bennett JM, Bejar R, Boultwood J, Loghavi S, Bewersdorf JP, Platzbecker U, Steensma DP, Sekeres MA, Buckstein RJ, Zeidan AM
20233394157310.1136/bmjspcare-2020-002312Fatigue in newly diagnosed acute myeloid leukaemia: general population comparison and predictive factors.BMJ supportive & palliative careOswald LB, Venditti A, Cella D, Cottone F, Candoni A, Melillo L, Cairoli R, Storti G, Salutari P, Luppi M, Albano F, Martelli MP, Cuneo A, Tafuri A, Trisolini SM, Tieghi A, Fazi P, Vignetti M, Efficace F
20223650454710.1097/HS9.0000000000000802Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review.HemaSphereEfficace F, Cannella L, Sparano F, Giesinger JM, Vignetti M, Baron F, Bruera E, Luppi M, Platzbecker U
20223635352910.3389/fonc.2022.991250Gratitude among advanced cancer patients and their caregivers: The role of early palliative care.Frontiers in oncologyBorelli E, Bigi S, Potenza L, Gilioli F, Artioli F, Porzio G, Porro CA, Efficace F, Bruera E, Luppi M, Bandieri E
20223626632610.1038/s41375-022-01724-9Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes.LeukemiaZeidan AM, Bewersdorf JP, Buckstein R, Sekeres MA, Steensma DP, Platzbecker U, Loghavi S, Boultwood J, Bejar R, Bennett JM, Borate U, Brunner AM, Carraway H, Churpek JE, Daver NG, Della Porta M, DeZern AE, Efficace F, Fenaux P, Figueroa ME, Greenberg P, Griffiths EA, Halene S, Hasserjian RP, Hourigan CS, Kim N, Kim TK, Komrokji RS, Kutchroo V, List AF, Little RF, Majeti R, Nazha A, Nimer SD, Odenike O, Padron E, Patnaik MM, Roboz GJ, Sallman DA, Sanz G, Stahl M, Starczynowski DT, Taylor J, Xie Z, Xu M, Savona MR, Wei AH, Abdel-Wahab O, Santini V
20223610277710.1016/S2666-7568(22)00172-6Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study.The lancet. Healthy longevityEfficace F, Gaidano G, Petrucci MT, Niscola P, Cottone F, Codeluppi K, Antonioli E, Tafuri A, Larocca A, Potenza L, Fozza C, Pastore D, Rigolin GM, Offidani M, Romano A, Kyriakou C, Cascavilla N, Gozzetti A, Derudas D, Vignetti M, Cavo M
20223564120710.1093/oncolo/oyab027Perceptions of Hope Among Bereaved Caregivers of Cancer Patients Who Received Early Palliative Care: A Content and Lexicographic Analysis.The oncologistBigi S, Ganfi V, Borelli E, Potenza L, Artioli F, Eliardo S, Mucciarini C, Cottafavi L, Cruciani M, Cacciari C, Odejide O, Porro CA, Zimmermann C, Efficace F, Bruera E, Luppi M, Bandieri E
20223561061110.1186/s12889-022-13211-yEORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.BMC public healthPilz MJ, Gamper EM, Efficace F, Arraras JI, Nolte S, Liegl G, Rose M, Giesinger JM,
20223537207910.3389/fonc.2022.826040Physicians' Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform.Frontiers in oncologyEfficace F, Patriarca A, Luppi M, Potenza L, Caocci G, Tafuri A, Fazio F, Cartoni C, Petrucci MT, Carmosino I, Moia R, Margiotta Casaluci G, Boggione P, Colaci E, Giusti D, Pioli V, Sparano F, Cottone F, De Fabritiis P, Ardu NR, Niscola P, Capodanno I, Leporace AP, Pelliccia S, Lugli E, La Sala E, Rigacci L, Santopietro M, Fozza C, Siragusa S, Breccia M, Fazi P, Vignetti M
20223532293210.1002/cam4.4692Patient-reported outcomes provide prognostic information for survival in patients with diffuse large B-cell lymphoma: Analysis of 1239 patients from the GOYA study.Cancer medicineHuang H, Datye A, Fan M, Knapp A, Nielsen T, Bottos A, Paulson JN, Trask PC, Efficace F
20223525515210.1111/bjh.18072International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia.British journal of haematologyOerlemans S, Efficace F, Kieffer JM, Kyriakou C, Xochelli A, Levedahl K, Petranovic D, Borges FC, Bredart A, Shamieh O, Gziskevicius L, Lehmann J, Scholz CW, Caocci G, Molica S, Stamatopoulos K, Panteliadou AK, Papaioannou M, Alrjoob W, Baliakas P, Rosenquist R, Malak S, Miranda A, Cocks K, van de Poll-Franse L,
20223518347610.1016/j.clml.2022.01.009Patient-Reported Outcomes in Randomized Controlled Trials of Patients with Multiple Myeloma: A Systematic Literature Review of Studies Published Between 2014 and 2021.Clinical lymphoma, myeloma & leukemiaEfficace F, Cottone F, Sparano F, Caocci G, Vignetti M, Chakraborty R
20223515874610.3390/cancers14030478Early Palliative Care in Acute Myeloid Leukemia.CancersPotenza L, Borelli E, Bigi S, Giusti D, Longo G, Odejide O, Porro CA, Zimmermann C, Efficace F, Bruera E, Luppi M, Bandieri E
20223509836610.1007/s00277-021-04750-2Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomy.Annals of hematologyCaocci G, Efficace F, Mulas O, Cottone F, Maxia A, Costa A, Simula MP, Usala E, La Nasa G
20223452160910.1016/j.jgo.2021.09.007Patient-reported outcomes predict overall survival in older patients with acute myeloid leukemia.Journal of geriatric oncologyPeipert JD, Efficace F, Pierson R, Loefgren C, Cella D, He J
20223450861010.1093/jnci/djab177Impact of Blinding on Patient-Reported Outcome Differences Between Treatment Arms in Cancer Randomized Controlled Trials.Journal of the National Cancer InstituteEfficace F, Cella D, Aaronson NK, Calvert M, Cottone F, Di Maio M, Perrone F, Sparano F, Gamper EM, Vignetti M, Giesinger JM
20223449268410.1182/bloodadvances.2021004568Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists.Blood advancesStojkov I, Conrads-Frank A, Rochau U, Koinig KA, Arvandi M, Puntscher S, van Marrewijk C, Fenaux P, Symeonidis A, Chermat F, Garelius H, Bowen D, Mittelman M, Mora E, de Witte T, Efficace F, Siebert U, Stauder R
20223449136410.1093/jnci/djab185Quality of Life Improvements in Patients With Chronic Myeloid Leukemia After Stopping Long-Term Therapy: Who Can Benefit the Most?Journal of the National Cancer InstituteEfficace F, Baccarani M
20213544470810.2174/1745017902117010307Health-Related Quality of Life Assessment in Patients with Myelodysplastic Syndromes: Evidence from Randomized Clinical Trials.Clinical practice and epidemiology in mental health : CP & EMHGiesinger JM, La Nasa G, Sparano F, Angermeyer M, Morelli E, Mulas O, Efficace F, Caocci G
20213483826810.1016/j.jval.2021.06.003Investigating Trends in the Quality of Reporting of Patient-Reported Outcomes in Oncology Over Time: Analysis of 631 Randomized Controlled Trials Published Between 2004 and 2019.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes ResearchEfficace F, Giesinger JM, Cella D, Cottone F, Sparano F, Vignetti M, Aaronson NK
20213475014510.1136/bmjspcare-2021-002898Early palliative/supportive care in acute myeloid leukaemia allows low aggression end-of-life interventions: observational outpatient study.BMJ supportive & palliative carePotenza L, Scaravaglio M, Fortuna D, Giusti D, Colaci E, Pioli V, Morselli M, Forghieri F, Bettelli F, Messerotti A, Catellani H, Gilioli A, Marasca R, Borelli E, Bigi S, Longo G, Banchelli F, D'Amico R, L Back A, Efficace F, Bruera E, Luppi M, Bandieri E
20213467076210.1136/bmjopen-2021-049128Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system.BMJ openRiva S, Arenare L, Di Maio M, Efficace F, Montesarchio V, Frontini L, Giannarelli D, Bryce J, Del Campo L, De Lorenzo F, Iannelli E, Traclò F, Gitto L, Jommi C, Vaccaro CM, Barberio D, Cinieri S, Porta C, Del Mastro L, Zagonel V, Cogoni AA, Bordonaro R, Gimigliano A, Piccirillo MC, Guizzaro L, Gallo C, Perrone F
20213452976810.1182/bloodadvances.2021004649Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy.Blood advancesEfficace F, Platzbecker U, Breccia M, Cottone F, Carluccio P, Salutari P, Di Bona E, Borlenghi E, Autore F, Levato L, Finizio O, Mancini V, D'Ardia S, Schlenk RF, Melillo L, Fumagalli M, Fiedler W, Beltrami G, Fracchiolla NS, Bernardi M, Fazi P, Annibali O, Mayer K, Voso MT, Vignetti M
20213451062410.1002/onco.13974Changes in Cancer Patients' and Caregivers' Disease Perceptions While Receiving Early Palliative Care: A Qualitative and Quantitative Analysis.The oncologistBorelli E, Bigi S, Potenza L, Eliardo S, Artioli F, Mucciarini C, Cottafavi L, Cagossi K, Razzini G, Cruciani M, Pietramaggiori A, Fantuzzi V, Lombardo L, Ferrari U, Ganfi V, Lui F, Odejide O, Cacciari C, Porro CA, Zimmermann C, Efficace F, Bruera E, Luppi M, Bandieri E
20213446190910.1186/s12955-021-01820-xGeneral Spanish population normative data analysis for the EORTC QLQ-C30 by sex, age, and health condition.Health and quality of life outcomesArraras JI, Nolte S, Liegl G, Rose M, Manterola A, Illarramendi JJ, Zarandona U, Rico M, Teiejria L, Asin G, Hernandez I, Barrado M, Vera R, Efficace F, Giesinger JM,
20213421939510.1002/cam4.4111International perspectives on suboptimal patient-reported outcome trial design and reporting in cancer clinical trials: A qualitative study.Cancer medicineRetzer A, Calvert M, Ahmed K, Keeley T, Armes J, Brown JM, Calman L, Gavin A, Glaser AW, Greenfield DM, Lanceley A, Taylor RM, Velikova G, Brundage M, Efficace F, Mercieca-Bebber R, King MT, Kyte D
20213412564210.1080/17474086.2021.1943352Health-related quality of life in patients with acute promyelocytic leukemia: a systematic literature review.Expert review of hematologyEfficace F, Cannella L, Breccia M, Olivieri J, Platzbecker U, Vignetti M
20213407585210.1080/17474086.2021.1938534Measuring prognosis in chronic myeloid leukemia: what's new?Expert review of hematologyBreccia M, Efficace F, Scalzulli E, Ciotti G, Maestrini G, Colafigli G, Martelli M
20213389058010.2196/25271The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study.JMIR research protocolsEfficace F, Breccia M, Fazi P, Cottone F, Holzner B, Vignetti M
20213384043710.1016/j.jval.2020.11.004Past and Current Practice of Patient-Reported Outcome Measurement in Randomized Cancer Clinical Trials: A Systematic Review.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes ResearchGiesinger JM, Efficace F, Aaronson N, Calvert M, Kyte D, Cottone F, Cella D, Gamper EM
20213378889310.1371/journal.pone.0248755Different semantic and affective meaning of the words associated to physical and social pain in cancer patients on early palliative/supportive care and in healthy, pain-free individuals.PloS oneBorelli E, Bigi S, Potenza L, Artioli F, Eliardo S, Mucciarini C, Cagossi K, Razzini G, Pasqualini A, Lui F, Ferlazzo F, Cruciani M, Bruera E, Efficace F, Luppi M, Cacciari C, Porro CA, Bandieri E
20213375322810.1016/j.jclinepi.2021.03.015The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3L.Journal of clinical epidemiologyGamper EM, Cottone F, Sommer K, Norman R, King M, Breccia M, Caocci G, Patriarca A, Palumbo GA, Stauder R, Niscola P, Platzbecker U, Caers J, Vignetti M, Efficace F
20213367765410.1007/s00277-021-04477-0Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients.Annals of hematologyScalzulli E, Caocci G, Efficace F, Rizzo L, Colafigli G, Di Prima A, Pepe S, Fegatelli DA, Carmosino I, Diverio D, Latagliata R, La Nasa G, Martelli M, Foà R, Breccia M
20213355467210.1080/17474086.2021.1886918Optimizing health-related quality of life in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.Expert review of hematologyEfficace F, Vignetti M, Sparano F, Scalzulli E, Breccia M
20213351803210.1016/j.jval.2020.10.017Patient-Reported Outcomes as Independent Prognostic Factors for Survival in Oncology: Systematic Review and Meta-Analysis.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes ResearchEfficace F, Collins GS, Cottone F, Giesinger JM, Sommer K, Anota A, Schlussel MM, Fazi P, Vignetti M
20213338886010.1007/s00277-020-04392-wLow-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib.Annals of hematologyCaocci G, Mulas O, Capodanno I, Bonifacio M, Annunziata M, Galimberti S, Luciano L, Tiribelli M, Martino B, Castagnetti F, Binotto G, Pregno P, Stagno F, Abruzzese E, Bocchia M, Gozzini A, Albano F, Fozza C, Luzi D, Efficace F, Simula MP, Scaffidi L, Baratè C, De Gregorio F, Stella R, Gugliotta G, Pirillo F, Trawinska MM, Sicuranza A, Cattaneo D, Attolico I, Scalzulli E, Iurlo A, Foà R, Breccia M, La Nasa G
20213327052910.1089/jpm.2020.0396Early Palliative Home Care versus Hospital Care for Patients with Hematologic Malignancies: A Cost-Effectiveness Study.Journal of palliative medicineCartoni C, Breccia M, Giesinger JM, Baldacci E, Carmosino I, Annechini G, Palumbo G, Armiento D, Niscola P, Tendas A, Brunetti GA, Minotti C, Marini MG, Reale L, Martone N, Martelli M, Efficace F
20213316575110.1007/s11523-020-00769-zDeveloping Symptom Lists for People with Cancer Treated with Targeted Therapies.Targeted oncologySodergren SC, Wheelwright SJ, Fitzsimmons D, Efficace F, Sprangers M, Fayers P, Harle A, Schmidt H, Bottomley A, Darlington AS, Benson C, Bredart A, Hentschel L, Arraras JI, Ioannidis G, Leahy M, Lugowska I, Nicolatou-Galitis O, Petranovic D, Rohde GE, Vassiliou V, Johnson CD,
20213315335510.1080/10428194.2020.1838509Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia.Leukemia & lymphomaEfficace F, Iurlo A, Patriarca A, Stagno F, Bee PC, Ector G, Capodanno I, Elena C, Bonifacio M, Blijlevens NMA, Caocci G, Wan C, Abruzzese E, Breccia M, Cottone F, Okumura I, Oerlemans S, Cascavilla N, Albano F, Kota V, Sztankay M, Miggiano MC, Saussele S, Di Renzo N, Sorà F, Castagnetti F, Baccarani M, Vignetti M, Rosti G
20213315069110.1002/onco.13587COVID-19 Pandemic and Cancer: The Importance of Early Palliative Care.The oncologistPotenza L, Luppi M, Efficace F, Bruera E, Bandieri E
20213309435710.1007/s00520-020-05840-zA qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerRiva S, Efficace F, Di Maio M, Bryce J, Del Campo L, De Lorenzo F, Frontini L, Giannarelli D, Gitto L, Iannelli E, Jommi C, Montesarchio V, Traclò F, Vaccaro CM, Arenare L, Canzanella G, Gimigliano A, Romano F, Savio A, Sparavigna L, Piccirillo MC, Guizzaro L, Gallo C, Perrone F
20203324244610.1016/S2352-3026(20)30292-1Quality of patient-reported outcome reporting in randomised controlled trials of haematological malignancies according to international quality standards: a systematic review.The Lancet. HaematologyChakraborty R, Cannella L, Cottone F, Efficace F
20203320569410.1080/17474086.2021.1852924Tyrosine kinase inhibitor discontinuation in the management of chronic myeloid leukemia: a critical review of the current practice.Expert review of hematologyBreccia M, Efficace F, Colafigli G, Scalzulli E, Di Prima A, Martelli M, Foà R